A rational diagnostic approach to peripheral neuropathy

Journal of Clinical Neuromuscular Disease

Volumn 4, Issue 4, 2003, Pages 190-198

  Smith, A Gordon ^a   Bromberg, Mark B ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN;

ALGORITHM; ANATOMY; CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; ELECTRODIAGNOSIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; MEDICAL SPECIALIST; NERVE BIOPSY; PATHOLOGY; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSORIMOTOR NEUROPATHY; SYMPTOMATOLOGY;

EID: 1642485195     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131402-200306000-00005     Document Type: Review

References (57)

1. The Italian General Practitioner Study Group. Chronic symmetric symptomatic polyneuropathy in the elderly: A field screening investigation in two Italian regions. I prevalence and general characteristics of the sample. Neurology. 1995;45:1832-1836.
2. Martyn C, Hughes R. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62:310-318.
3. Dyck PJ, Dyck JB, Grant IA, et al. Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology. 1996;47:10-17.
4. Bromberg M, Smith A. Toward an efficient method to evaluate peripheral neuropathies. J Clin Neuromusc Dis. 2002;3:172-182.
5. Donofrio PD, Albers JW. AAEM minimonograph #34: polyneuropathy: Classification by nerve conduction studies and electromyography. Muscle Nerve. 1990; 13:889-903.
6. Wolfe G, Baker N, Amato A, et al. Chronic cryptogenic sensory polyneuropathy clinical and laboratory characteristics. Arch Neurol. 1999;56:540-547.
7. Koller W, Gehlmann L, Malkinson F, et al. Dapsone induced peripheral neuropathy. Arch Neurol. 1977;10:644-646.
8. Feldman RG, Hayes MK, Younes R, et al. Lead neuropathy in adults and children. Arch Neurol. 1977;34:481-488.
9. Barats M, Gonck H, Rothenberg S, et al. Severe lead induced peripheral neuropathy in a dialysis patient. Am J Kidney Dis. 2000;35:963-968.
10. Pestronk A, Lopate G, Kornberg AJ, et al. Distal lower motor neuron syndrome with high titer serum IgM anti-Gm antibodies. Neurology. 1994;44:2027-2031.
11. Taylor B, Wright R, Harper C, et al. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve. 2000;23:900-908.
12. Chaudhry V. Multifocal motor neuropathy. Semin Neurol. 1998; 18:73-81.
13. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: Response to human immune globulin. Ann Neurol. 1993;33:237-242.
14. Katz J, Saperstein D, Wolfe G, et al. Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle Nerve. 2001;24:794-798.
15. Albers J, Robertson W, Daube J. Electrodiagnostic findings in acute porphyric neuropathy. Muscle Nerve. 1978;1:292-296.
16. Barohn R. Approach to peripheral neuropathy and neuropathy. Semin Neurol. 1998;18:7-18.
17. Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse a new megavitamin syndrome. N Engl J Med. 1983;309:445-448.
18. Auger RG, Windebank AJ, Lucchinettic C, et al. Role of the blink reflex in the evaluation of sensory neuropathy. Neurology. 1999;53:407-408.
19. Collins M, Mendell J, Periquer M, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitis neuropathy. Neurology. 2000;55:636-643.
20. Mouton P, Tardieu S, Gouider R, et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology. 1999;52:1440-1446.
21. Li J, Krajewski K, Shy ME, et al. Hereditary neuropathy with liability to pressure palsy: The electrophysiology fits the name. Neurology. 2002;58:1769-1773.
22. Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndrome. Muscle Nerve. 1999;22:560-566.
23. Nations S, Katz JS, Lyde C, et al. Leprous neuropathy: An American perspective. Semin Neurol. 1998;18:113-124.
24. Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment. Muscle Nerve. 2002;25:477-491.
25. Said G, Elgrably F, Lacroix C, et al. Painful proximal diabetic neuropathy: Inflammatory nerve lesions and spontaneous favorable outcome. Ann Neurol. 1997;41:762-770.
26. Wulff E, Simpson D. Neuromuscular complications of the human immunodeficiency virus type 1 infection. Semin Neurol. 1999;19:157-164.
27. Brady R, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA. 2001;284:2771-2775.
28. Graf W, Chance P, Lensch M, et al. Severe vincristine neuropathy in Charcot Marie Tooth disease type 1A. Cancer. 1996;77: 1356-1362.
29. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981;10:222-226.
30. Dyck P, Dyck J, Chalk C. The 10 P's: A mnemonic helpful in characterization of differential diagnosis of peripheral neuropathy. Neurology. 1992;41:14-18.
31. Hoogendijk JE, De Visser M, Bolhuis PA, et al. Hereditary motor and sensory neuropathy type I: Clinical and neurographical features of the 17p duplication subtype. Muscle Nerve. 1994;17: 85-90.
32. Lewis R. The challenge of CMTX and connexin 32 mutations. Muscle Nerve. 2000;23:147-149.
33. Bennett CL, Chance PF. Molecular pathogenesis of hereditary motor, sensory and autonomic neuropathies. Curr Opin Neurol. 2001;14:621-627.
34. Gorson K, Ropper A. Idiopathic distal small fiber neuropathy. Acta Neurol Scand. 1995;92:376-382.
35. Periquet MI, Novak V, Collins MP, et al. Painful sensory neuropathy prospective evaluation using skin biopsy. Neurology. 1999;53:1641-1647.
36. McArthur JC, Stocks EA, Hauer P, et al. Epidermal nerve fiber density normative reference range and diagnostic efficiency. Arch Neurol. 1998;55:1513-1520.
37. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001;24:1448-1453.
38. Singleton JR, Smith AG, Bromberg MB. Painful sensory neuropathy associated with impaired glucose tolerance. Muscle Nerve. 2001;24:1225-1228.
39. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24:1229-1231.
40. Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
41. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
42. Saperstein DS, Barohn RJ. Peripheral neuropathy due to cobalamin deficiency. Curr Treat Options Neurol. 2002;4:197-201.
43. Duyff R, Van den Bosch J, Laman D, et al. Neuromuscular findings in thyroid dysfunction: A prospective clinical and electrodiagnostic Study. J Neurol Neurosurg Psychiatry. 2000;68:750-755.
44. Kelly J, Kyle R, O'Brien P, et al. Prevalence of monoclonal proteins in peripheral neuropathy. Neurology. 1981;31:1480-1483.
45. Kyle RA, Finkelstein S, Elveback LR, et al. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood. 1972;40:719-724.
46. Notermans N, Wokke J, Lokhorst H, et al. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: A prospective study of the prognostic value of clinical and laboratory abnormalities. Brain. 1994;117:1385-1393.
47. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564-569.
48. Grant IA, Hunder GG, Homburger HA, et al. Peripheral neuropathy associated with sicca complex. Neurology. 1997;48:855-862.
49. Azizah MR, Azila MN, Zulkifli MN, et al. The prevalence of antinuclear, anti-dsDNA and anti-RNP antibodies in a group of healthy blood donors. Asian Pac J Allergy Immunol. 1996;14: 125-128.
50. de Vlam K, De Keyser F, Vergraggen G, et al. Detection and identification of antinuclear antibodies in serum of normal blood donors. Clin Exp Rheumatol. 1993;11:393-397.
51. Wolfe G, El-Feky W, Katz J, et al. Antibody panels in idiopathic polyneuropathy and motor neuron disease. Muscle Nerve. 1997; 20:1275-1283.
52. Verghese J, Bieri P, Gellido C, et al. Peripheral neuropathy in young-old and old-old patients. Muscle Nerve. 2001;24:1476-1481.
53. Vrancken AF, Franssen H, Wokke JH, et al. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people. Arch Neurol. 2002;59:533-540.
54. Wolfe GI. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system. Arch Neurol. 2002;59:520-522.
55. Notermans N, Wokke J, van der Graaf Y, et al. Chronic idiopathic axonal polyneuropathy: A five year follow up. J Neurol Neurosurg Psychiatry. 1994;57:1525-1527.
56. Jann S, Beretta S, Bramerio M, et al. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve. 2001;24:1197-1201.
57. Kelkar P, McDermott WR, Parry GJ. Sensory-predominant, painful, idiopathic neuropathy: Inflammatory changes in sural nerves. Muscle Nerve. 2002;26:413-416.